Sheng-Pu has entered its 50th year since its start. With the aim to study Chinese Medicine scientifically, we invested in a four-year research and testing of Chinese herbs in the Pharmacology and Toxicology department as well as the Neuroscience department of USC. The research results have been published in the The American Journal of Chinese Medicine and Hepatology. In addition, the establishment of Sheng-Pu North America factory made it possible to use the latest technology to produce high-quality and curative Chinese herbal medicine under strict quality regulations. We continue to cooperate with American universities and research institutions.
Since our research reports are published in the journal, we cannot provide the original copy. Here’s a link to the study of SP Pro-liver Pill (YGW) at the National Institutes of Health:
Protective effect of SP Pro-liver Pill (YGW) on chemical liver injury in mice
SP Pro-liver Pill (YGW) protects mice against apoptosis induced by anti-Fas antibody (Jo2)
SP Pro-liver Pill (YGW) protects the liver
Genetic activity of rosemary acid and baicalein in the epigenetic defibrillation of PPARγ in hepatocytes
Summer is gradually leaving, early autumn is quietly cool, and the changing climate makes it easy for people to catch a cold accidentally. Influenza is
Talking about the change in drug colors! A visit to the hospital reveals that apart from anti-cancer chemotherapy drugs, the medication that patients are most
With the spread of the H7N9 avian influenza epidemic in China and the death of a new coronavirus infection in the Middle East, countries are
